Luyan Pharma Co.,Ltd.
SZSE:002788.SZ
8.78 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 606.303 | 594.19 | 415.434 | 595.366 | 428.935 | 516.717 | 541.809 | 424.704 | 470.254 | 579.707 | 355.948 | 282.918 | 170.688 |
| Short Term Investments
| -52.362 | -24.683 | -37.735 | -39.194 | -41.764 | -41.529 | -36.42 | 14.875 | 14 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 606.303 | 594.19 | 415.434 | 595.366 | 428.935 | 516.717 | 541.809 | 424.704 | 470.254 | 579.707 | 355.948 | 282.918 | 170.688 |
| Net Receivables
| 6,082.536 | 6,565.584 | 5,572.432 | 4,422.623 | 4,051.907 | 3,132.902 | 2,620.49 | 1,783.869 | 1,938.697 | 1,761.412 | 1,620.651 | 1,319.413 | 853.593 |
| Inventory
| 2,574.076 | 2,548.589 | 2,274.989 | 2,028.122 | 1,758.7 | 1,290.739 | 1,067.738 | 747.765 | 570.311 | 528.969 | 470.377 | 425.775 | 222.262 |
| Other Current Assets
| 55.659 | 39.877 | 59.433 | 46.433 | 51.183 | 41.971 | 49.585 | 27.351 | 7.731 | 6.464 | 6.109 | 11.191 | -13.209 |
| Total Current Assets
| 9,318.574 | 9,748.241 | 8,322.289 | 7,092.544 | 6,290.726 | 4,982.328 | 4,279.622 | 2,983.689 | 2,986.993 | 2,876.552 | 2,453.086 | 2,039.296 | 1,233.334 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 1,652.934 | 1,425.217 | 1,036.656 | 825.412 | 744.655 | 623.376 | 555.12 | 401.725 | 317.631 | 317.77 | 280.239 | 147.54 | 65.708 |
| Goodwill
| 288.651 | 289.451 | 289.451 | 283.883 | 301.383 | 289.164 | 119.234 | 28.136 | 33.969 | 35.437 | 35.419 | 11.705 | 7.171 |
| Intangible Assets
| 355.164 | 176.934 | 167.81 | 113.234 | 117.28 | 108.251 | 82.179 | 60.098 | 61.677 | 62.37 | 33.159 | 15.726 | 15.451 |
| Goodwill and Intangible Assets
| 643.815 | 466.385 | 457.261 | 397.117 | 418.664 | 397.415 | 201.413 | 88.233 | 95.646 | 97.807 | 68.578 | 27.431 | 22.622 |
| Long Term Investments
| 101.214 | 58.889 | 69.035 | 39.494 | 42.064 | 41.829 | 36.92 | 23.406 | 18.003 | 14.872 | 7.77 | 0 | 0 |
| Tax Assets
| 66.374 | 54.709 | 43.393 | 35.094 | 28.553 | 23.325 | 23.502 | 14.358 | 10.03 | 6.797 | 5.969 | 3.366 | 1.22 |
| Other Non-Current Assets
| 10.683 | 30.355 | 64.062 | 45.222 | 13.33 | 2.244 | 35.846 | 0.047 | 0.711 | 0.21 | 10 | 6.798 | 5.193 |
| Total Non-Current Assets
| 2,475.021 | 2,035.555 | 1,670.406 | 1,342.339 | 1,247.266 | 1,088.188 | 852.801 | 527.77 | 442.022 | 437.456 | 372.556 | 185.134 | 94.743 |
| Total Assets
| 11,793.594 | 11,783.796 | 9,992.695 | 8,434.883 | 7,537.992 | 6,070.517 | 5,132.423 | 3,511.458 | 3,429.015 | 3,314.008 | 2,825.642 | 2,224.431 | 1,328.077 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 3,444.468 | 3,258.174 | 2,410.5 | 2,004.961 | 1,915.093 | 1,681.683 | 1,309.918 | 1,146.573 | 1,458.065 | 1,463.22 | 1,261.228 | 1,116.683 | 668.988 |
| Short Term Debt
| 4,187.363 | 4,535.903 | 4,207.89 | 3,370.586 | 3,136.863 | 2,151.754 | 1,744.097 | 901.363 | 1,139.568 | 1,114.182 | 909.74 | 546.26 | 272.202 |
| Tax Payables
| 68.989 | 71.182 | 71.787 | 64.527 | 48.111 | 48.617 | 40.77 | 20.199 | 24.256 | 17.379 | 22.649 | 17.654 | 10.282 |
| Deferred Revenue
| 391.436 | 31.784 | 394.933 | 437.262 | 417.196 | 48.617 | 304.986 | 60.719 | 61.289 | 66.802 | 73.269 | 102.947 | 29.102 |
| Other Current Liabilities
| 2.891 | 475.15 | 1.907 | 2.492 | 37.87 | 332.686 | 35.716 | 0.5 | 3.354 | 2.397 | 6.013 | 9.707 | 2.055 |
| Total Current Liabilities
| 8,026.158 | 8,301.01 | 7,015.23 | 5,815.3 | 5,507.022 | 4,214.74 | 3,394.718 | 2,109.155 | 2,662.276 | 2,646.602 | 2,250.25 | 1,775.597 | 972.346 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 652.957 | 525.623 | 263.858 | 110.99 | 116.7 | 119.4 | 48.8 | 15.654 | 16.661 | 13.805 | 13.759 | 0 | 0 |
| Deferred Revenue Non-Current
| 39.756 | 41.198 | 41.852 | 11.196 | 7.377 | 8.438 | 8.794 | 8.169 | 3.778 | 3.997 | 3.367 | 0.285 | 0 |
| Deferred Tax Liabilities Non-Current
| 6.805 | 7.073 | 7.342 | 7.634 | 6.454 | 6.187 | 64.951 | -15.355 | -16.362 | -13.506 | -2.972 | 0 | 0 |
| Other Non-Current Liabilities
| 90.978 | 118.242 | 104.284 | 83.515 | 12.42 | 68.174 | 48.8 | 15.654 | 16.661 | 13.805 | 3.367 | 0.396 | 0.819 |
| Total Non-Current Liabilities
| 790.496 | 692.137 | 417.336 | 213.335 | 142.951 | 202.199 | 171.345 | 24.121 | 20.738 | 18.102 | 17.52 | 0.681 | 0.819 |
| Total Liabilities
| 8,816.654 | 8,993.147 | 7,432.566 | 6,028.635 | 5,649.973 | 4,416.939 | 3,566.063 | 2,133.277 | 2,683.015 | 2,664.703 | 2,267.77 | 1,776.278 | 973.165 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.131 | 0.186 | 0 | 0 |
| Common Stock
| 388.517 | 388.517 | 388.517 | 388.517 | 326.83 | 192.253 | 128.169 | 128.169 | 96.119 | 96.119 | 96.119 | 96.119 | 96.119 |
| Retained Earnings
| 1,723.568 | 1,491.266 | 1,291.506 | 1,098.667 | 915.393 | 710.702 | 632.166 | 538.798 | 461.634 | 376.836 | 293.626 | 192.891 | 107.221 |
| Accumulated Other Comprehensive Income/Loss
| 206.126 | 190.434 | 158.274 | 130.935 | 92.674 | 79.304 | 66.113 | 55.952 | 41.976 | -0.131 | -0.186 | 0 | 0 |
| Other Total Stockholders Equity
| 628.048 | 650.596 | 653.368 | 722.355 | 456.791 | 587.126 | 647.271 | 647.271 | 137.837 | 169.315 | 164.057 | 156.695 | 150.696 |
| Total Shareholders Equity
| 2,946.258 | 2,720.813 | 2,491.664 | 2,340.475 | 1,791.689 | 1,569.385 | 1,473.719 | 1,370.19 | 737.565 | 642.27 | 553.802 | 445.705 | 354.035 |
| Total Equity
| 2,976.941 | 2,790.649 | 2,560.13 | 2,406.248 | 1,888.019 | 1,653.577 | 1,566.36 | 1,378.181 | 746.001 | 649.305 | 557.871 | 448.152 | 354.912 |
| Total Liabilities & Shareholders Equity
| 11,793.594 | 11,783.796 | 9,992.695 | 8,434.883 | 7,537.992 | 6,070.517 | 5,132.423 | 3,511.458 | 3,429.015 | 3,314.008 | 2,825.642 | 2,224.431 | 1,328.077 |